Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Pediatric Blood & Cancer|June 5, 2020
Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medicationsJennifer Young, Devesh Dahale, Kathleen Demmel, et al.
Journal of the American Association of Nurse Practitioners|March 13, 2026
Aging with grace: Intraprofessional nursing simulation to improve Hawai'i's geriatrics workforce readinessCourtnee Nunokawa, Lorrie Wong, Kamal Masaki, et al.
Journal of Youth and Adolescence|July 22, 2023
Developmental Changes in the Relation between Youth Disclosure and Parenting Behavior: A Cohort-sequential AnalysisSara E Goldstein, Meagan Docherty, Paul Boxer, et al.
JMIR Formative Research|February 4, 2020
Development of a National Caregiver Health Survey for Hematopoietic Stem Cell Transplant: Qualitative Study of Cognitive Interviews and Verbal ProbingJacob Kedroske, Sarah Koblick, Dima Chaar, et al.
Pediatric Transplantation|December 3, 2014
The use of a Berlin Heart EXCOR LVAD in a child receiving chemotherapy for Castleman's diseaseTamara O Thomas, Shanmuganathan Chandrakasan, Maureen O'Brien, et al.
Alimentary Pharmacology & Therapeutics|November 14, 2025
Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and ExpansionCathy Lu, Bram Verstockt, Michael W Winter, et al.
Cancer|April 29, 2021
Training oncology care providers in the assessment and treatment of tobacco use and dependenceJamie S Ostroff, Kemi L Bolutayo Gaffney, Maureen O'Brien, et al.
Transfusion|July 16, 2015
Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantationTina Pham, Sushrut Patil, Shaun Fleming, et al.
British Journal of Haematology|February 26, 2013
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adultsChristine L Phillips, Stella M Davies, Richard McMasters, et al.
Blood|July 28, 2021
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trialJohann Hitzler, Todd Alonzo, Robert Gerbing, et al.
Pageof 4